AccuStem Sciences, Inc. Announces Chairman Purchase of Shares

Contributed by: GlobeNewswire

Tags

Shares Purchase

More Like This

STEMCELL Technologies is pleased to announce the acquisition of substantially all assets of SQZ Biotechnologies Company (SQZ)—a Massachusetts-based biotech known for its game-changing method of introducing a variety of therapeutic cargo into cells by squeezing them (mechanoporation) rather than using electricity (electroporation). This transaction, which was approved by SQZ shareholders on February 29, 2024, marks another significant milestone for STEMCELL, Canada’s largest biotechnology company. (Photo: Business Wire)

STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Company

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

Business Wire logo

Instem Now Part of ARCHIMED to Further Accelerate Growth and Impact

Merus to Present at Canaccord Genuity’s 44th Annual Growth Conference

BerGenBio Collaborates with Tempus to Potentially Accelerate Development in STK11m Non-Small Cell Lung Cancer

Business Wire logo

Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress

PR Newswire associated0

Cumulus Neuroscience to Join Bio-Hermes 2 Study with Funding from the Innovate UK Small Business Research Initiative (SBRI) Dementia Mission Project

Business Wire logo

Merz Enters Asset Purchase Agreement With a US-Based Biotech Company